Related Experiment Videos
Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome
N Hayashi1, H Higashi, K Kaminaka
1First Department of Pathology, Nihon University, School of Medicine, Tokyo, Japan.
Insights
Researchers cloned the Japanese hepatitis C virus (HCV-N) genome using RT-PCR. Sequence analysis revealed HCV-N belongs to group II, highlighting conserved regions for diagnostics and diverse regions for vaccine development.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Hepatitis C virus (HCV) infection is a global health concern.
- Understanding HCV genetic diversity is crucial for diagnostics and therapeutics.
- Previous studies have characterized various HCV isolates, but a comprehensive analysis of the Japanese variant was needed.
Purpose of the Study:
- To clone and characterize the complete genome of the Japanese hepatitis C virus variant (HCV-N).
- To analyze the genetic relatedness of HCV-N to other known HCV isolates.
- To identify conserved and diverse regions within the HCV genome for potential diagnostic and therapeutic targets.
Main Methods:
- Cloning of the HCV-N genome from patient plasma using reverse transcription-polymerase chain reaction (RT-PCR) and modified RT-PCR.
- Comparative sequence analysis of HCV-N with existing HCV genome sequences.
- Phylogenetic analysis to determine the grouping of HCV-N.
Main Results:
- The complete 9440-nucleotide HCV-N genome was successfully cloned.
- HCV-N possesses a 4-amino acid insertion in the NS5 region, found to be rare.
- Sequence analysis classified HCV-N into group II, showing high homology (>90%) with HCV-J and HCV-BK.
- The 5' non-coding region was highly conserved (>93%), suitable for sensitive RT-PCR detection of HCV RNA.
- The putative core protein region showed high similarity, indicating potential for immunoassay development.
- High diversity in the putative envelope protein region suggests a role in HCV chronicity and vaccine development.
Conclusions:
- The study successfully characterized the HCV-N genome, providing insights into its genetic makeup.
- The conserved 5' non-coding region is a valuable target for developing sensitive HCV RNA detection assays.
- The diverse envelope protein region presents challenges for vaccine development but is critical for understanding disease chronicity.
Abstract:
The Japanese variant of the hepatitis C virus (HCV-N) genome, consisting of 9440 nucleotides in length, was cloned from a small amount (2 ml) of plasma from a single Japanese carrier by using RT-PCR and modified RT-PCR. The HCV-N genome has a long open reading frame that encodes a 3014 amino acid polyprotein with 340 and 57 bases of 5' and 3' non-coding sequences, respectively. HCV-N has a 4-amino-acid insertion in the NS5 region as compared to other HCV isolates, but this insertion is found to be very rare upon direct sequencing of that region. Comparative sequence analysis of all the complete and partial HCV sequences that were reported indicates that HCV can be subdivided into at least 4 groups. The HCV-N isolate has a high homology with HCV-J and HCV-BK (> 90%) and so belongs to group II, but shows less similarity to HCV-1 (> 78%, group I) and least to HC-J6 (> 67%, group III). Among these HCV isolates, the 5' non-coding region was the most conserved (> 93%) since it plays an important role in replication. The RT-PCR assay to detect HCV-RNA, using the primers deduced from this region, was very sensitive and specific. The putative core protein could become an important target for immunoassay because of a high degree of amino acid sequence similarity in that region. A high degree of diversity and a low similarity between each HCV isolate in the putative envelope protein play an important role in the chronicity of HCV infection and development of immunopreventive agents, such as immunoglobulin and vaccine for that infection.